Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism

Liraglutide is a glucagon-like peptide-1 (GLP-1) mimetic used for the treatment of Type 2 diabetes. Similar to the actions of endogenous GLP-1, liraglutide potentiates the post-prandial release of insulin, inhibits glucagon release and increases satiety. Recent epidemiological studies and clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Krasner, Nadia M., Ido, Yasuo, Ruderman, Neil B., Cacicedo, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023984/
https://www.ncbi.nlm.nih.gov/pubmed/24835252
http://dx.doi.org/10.1371/journal.pone.0097554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023984/
https://www.ncbi.nlm.nih.gov/pubmed/24835252
http://dx.doi.org/10.1371/journal.pone.0097554

Ejemplares similares